Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
infection (CDI) is the leading cause of nosocomial antibiotic-associated diarrhea, and colitis, with increasing incidence and healthcare costs. Its pathogenesis is primarily driven by toxins produced by the bacterium , Toxin A (TcdA) and Toxin B (TcdB). Certain strains produce an additional toxin, the transferase (CDT), which further enhances the virulence and pathogenicity of . These toxins disrupt colonic epithelial barrier integrity, and induce inflammation and cellular damage, leading to CDI symptoms. Significant progress has been made in the past decade in elucidating the molecular mechanisms of TcdA, TcdB, and CDT, which provide insights into the management of CDI and the future development of novel treatment strategies based on anti-toxin therapies. While antibiotics are common treatments, high recurrence rates necessitate alternative therapies. Bezlotoxumab, targeting TcdB, is the only available anti-toxin, yet limitations persist, prompting ongoing research. This review highlights the current knowledge of the structure and mechanism of action of toxins and their role in disease. By comprehensively describing the toxin-mediated mechanisms, this review provides insights for the future development of novel treatment strategies and the management of CDI.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11124097 | PMC |
| http://dx.doi.org/10.3390/microorganisms12051004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Advances in Understanding the Pathogenesis of Clostridioides difficile Infection.
Infect Dis Clin North Am
September 2025
Department of Microbiology, Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, 303B Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104, USA.
Clostridioides difficile infection (CDI) remains a significant cause of infectious colitis in the United States. Susceptibility to CDI is associated with perturbation of the gut microbiota, the indigenous microbes in the gastrointestinal tract. Upon colonization, the production of toxins and the ability to produce spores for environmental dissemination contribute to C difficile pathogenicity.
View Article and Find Full Text PDFGinsenoside Rg1 mitigates the prolonged isoflurane anesthesia-induced neuroimmune disruptions.
J Ethnopharmacol
August 2025
NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Jiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Anesthesiology, Affiliated
Ethnopharmacological Relevance: Ginsenoside Rg1, a primary bioactive component of Panax ginseng, has been historically used in traditional Chinese medicine to replenish qi, nourish vitality, and restore cognitive function. Its neuroprotective properties have been documented in conditions involving neurological exhaustion and immune dysregulation.
Aim Of The Study: This study investigated the therapeutic potential and mechanisms of ginsenoside Rg1 in mitigating neurobehavioral and systemic immune dysfunction induced by prolonged general anesthesia.
Myocarditis Triggered by Erysipelas: A Rare Infectious Complication.
JACC Case Rep
July 2025
Department of Cardiology and Internal Intensive Care Medicine, Vivantes Friedrichshain Berlin, Berlin, Germany.
Background: Myocarditis is an inflammatory disease of the myocardium often triggered by viral infections. However, bacterial causes, such as group A β-hemolytic Streptococcus, are less common but clinically significant.
Case Summary: A 26-year-old man presented with acute chest pain after erysipelas of the right foot.
A 3D-printed chitosan-based pH-responsive dual functional scaffold for osteomyelitis: synergistic antibacterial and osteogenic treatment.
Carbohydr Polym
October 2025
Analytical & Testing Center, Sichuan University, Chengdu 610064, PR China. Electronic address:
Despite advances in osteomyelitis treatment, achieving spatiotemporal coordination of infection control and bone regeneration remains challenging due to bacterial-induced acidic microenvironments and toxin-mediated osteoblast dysfunction. Herein, a novel 3D-printed chitosan-based composite scaffold (VM@n-HA/CS/DM) was developed. The scaffold strategically integrates two functional components: (1) Vancomycin-loaded chitosan microspheres (VM) conjugated with scaffold via pH-sensitive Schiff base bonds formed between aldehyde and amine groups, selectively breaking down in the acidic microenvironment of bacterial infections, thereby enabling on-demand release of vancomycin (Van) to target and eliminate Staphylococcus aureus (S.
View Article and Find Full Text PDFin Animal Inflammatory Bowel Disease: A One Health Perspective on Emerging Zoonotic Threats.
Microorganisms
May 2025
School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Inflammatory bowel disease (IBD) in animals, a multifactorial gastrointestinal disorder marked by chronic inflammation, has increasingly been linked to infections. Recognized for its pathogenic role in human pseudomembranous colitis, is now emerging as a critical agent in veterinary medicine, particularly in livestock (e.g.
View Article and Find Full Text PDF